Tamiflu - Revision history

Jewish Charity Bot: Category overhaul (approved)

2026-10-17T12:56:51Z

Category overhaul (approved)

Claire Robinson: /* WHO's lack of Transparency */

2010-03-29T12:45:29Z

WHO's lack of Transparency

Marisa de Andrade at 12:40, 29 March 2010

2010-03-29T12:40:15Z

Claire Robinson: /* "Swine flu clears old stock of Tamiflu" allegation */

2009-07-15T13:19:54Z

"Swine flu clears old stock of Tamiflu" allegation

Claire Robinson: /* "Swine flu clears old stock of Tamiflu" allegation */

2009-07-15T13:19:07Z

"Swine flu clears old stock of Tamiflu" allegation

Claire Robinson at 13:18, 15 July 2009

2009-07-15T13:18:40Z

Claire Robinson: /* Extended Clinical Trials and Developments */

2009-07-15T13:04:19Z

Extended Clinical Trials and Developments

David at 12:15, 15 July 2009

2009-07-15T12:15:28Z

Claire Robinson: /* Side-effects */

2009-07-15T10:30:52Z

Side-effects

Claire Robinson at 10:30, 15 July 2009

2009-07-15T10:30:24Z

← Older revision		Revision as of 12:56, 17 October 2026
Line 70:		Line 70:

	[[Category: Big Pharma]]		[[Category: Big Pharma]]
−	[[Category: ~~Pharma~~]]	+	[[Category:Pharmaceutical Industry]]

← Older revision		Revision as of 12:45, 29 March 2010
Line 61:		Line 61:

	:"The neutrality of their advice could be contested...To date, WHO has failed to provide convincing evidence to counter these allegations and the organisation has not published the relevant declarations of interest. Taking such a reserved position, the organisation has joined other bodies, such as the European Medicines Agency [[EMEA]], which likewise, have still not published such documents."<ref>Boseley, S. 28 March 2010. ''The Guardian.'' [http://www.guardian.co.uk/world/2010/mar/28/who-public-confidence-flu-pandemic WHO accused of losing public confidence over flu pandemic] Accessed 29 March 2010.</ref>		:"The neutrality of their advice could be contested...To date, WHO has failed to provide convincing evidence to counter these allegations and the organisation has not published the relevant declarations of interest. Taking such a reserved position, the organisation has joined other bodies, such as the European Medicines Agency [[EMEA]], which likewise, have still not published such documents."<ref>Boseley, S. 28 March 2010. ''The Guardian.'' [http://www.guardian.co.uk/world/2010/mar/28/who-public-confidence-flu-pandemic WHO accused of losing public confidence over flu pandemic] Accessed 29 March 2010.</ref>
		+
		+	==Resources==
		+	*[[Pandemics]]
		+	*[[Swine Flu]]

	==Notes==		==Notes==

@@ Line 51: / Line 51: @@
 In April 2009 the website What Doctors Don't Tell You (WDDTY) reported that swine flu had arrived at a convenient time to enable governments to clear old stockpiles of Tamiflu left over from the avian flu epidemic:
 :It is almost three years since we faced the hysteria of an avian flu epidemic, when governments bought billions of dollars of Tamiflu – the same anti-viral now being promoted to combat a supposed swine flu pandemic.  The shelf life of Tamiflu also happens to be three years. The World Health Organization has, at the time of writing, increased its threat level to five, which means governments can activate their pandemic plans – and start handing out Tamiflu drugs. This is extremely convenient for governments that would have very soon have to dispose of billions of dollars of Tamiflu stock, which they bought to counter avian flu, or H5N1.  The US government ordered 20 million doses, costing $2bn, in October, 2005, and around that time the UK government ordered 14.6 million doses.  Tamiflu’s manufacturer, Roche, has confirmed that the shelf life of its anti-viral is three years.<ref>[http://www.wddty.com/swine-flu-alert-clears-old-stock-of-tamiflu.html Swine flu alert clears old stock of Tamiflu] (subscription req'd to see full article), 30 April 2009, WDDTY website, accessed 15 July 2009</ref>
 ==Notes==

@@ Line 49: / Line 49: @@
 =="Swine flu clears old stock of Tamiflu" allegation==
-The website What Doctors Don't Tell You (WDDTY) reports that swine flu has arrived at a convenient time to enable governments to clear old stockpiles of Tamiflu left over from the avian flu epidemic:
+In April 2009 the website What Doctors Don't Tell You (WDDTY) reported that swine flu had arrived at a convenient time to enable governments to clear old stockpiles of Tamiflu left over from the avian flu epidemic:
 :It is almost three years since we faced the hysteria of an avian flu epidemic, when governments bought billions of dollars of Tamiflu – the same anti-viral now being promoted to combat a supposed swine flu pandemic.  The shelf life of Tamiflu also happens to be three years. The World Health Organization has, at the time of writing, increased its threat level to five, which means governments can activate their pandemic plans – and start handing out Tamiflu drugs. This is extremely convenient for governments that would have very soon have to dispose of billions of dollars of Tamiflu stock, which they bought to counter avian flu, or H5N1.  The US government ordered 20 million doses, costing $2bn, in October, 2005, and around that time the UK government ordered 14.6 million doses.  Tamiflu’s manufacturer, Roche, has confirmed that the shelf life of its anti-viral is three years.<ref>[http://www.wddty.com/swine-flu-alert-clears-old-stock-of-tamiflu.html Swine flu alert clears old stock of Tamiflu] (subscription req'd to see full article), 30 April 2009, WDDTY website, accessed 15 July 2009</ref>

@@ Line 50: / Line 50: @@
 The website What Doctors Don't Tell You (WDDTY) reports that swine flu has arrived at a convenient time to enable governments to clear old stockpiles of Tamiflu left over from the avian flu epidemic:
-"It is almost three years since we faced the hysteria of an avian flu epidemic, when governments bought billions of dollars of Tamiflu – the same anti-viral now being promoted to combat a supposed swine flu pandemic.  The shelf life of Tamiflu also happens to be three years. The World Health Organization has, at the time of writing, increased its threat level to five, which means governments can activate their pandemic plans – and start handing out Tamiflu drugs. This is extremely convenient for governments that would have very soon have to dispose of billions of dollars of Tamiflu stock, which they bought to counter avian flu, or H5N1.  The US government ordered 20 million doses, costing $2bn, in October, 2005, and around that time the UK government ordered 14.6 million doses.  Tamiflu’s manufacturer, Roche, has confirmed that the shelf life of its anti-viral is three years.<ref>[http://www.wddty.com/swine-flu-alert-clears-old-stock-of-tamiflu.html Swine flu alert clears old stock of Tamiflu] (subscription req'd to see full article), 30 April 2009, WDDTY website, accessed 15 July 2009</ref>
+:It is almost three years since we faced the hysteria of an avian flu epidemic, when governments bought billions of dollars of Tamiflu – the same anti-viral now being promoted to combat a supposed swine flu pandemic.  The shelf life of Tamiflu also happens to be three years. The World Health Organization has, at the time of writing, increased its threat level to five, which means governments can activate their pandemic plans – and start handing out Tamiflu drugs. This is extremely convenient for governments that would have very soon have to dispose of billions of dollars of Tamiflu stock, which they bought to counter avian flu, or H5N1.  The US government ordered 20 million doses, costing $2bn, in October, 2005, and around that time the UK government ordered 14.6 million doses.  Tamiflu’s manufacturer, Roche, has confirmed that the shelf life of its anti-viral is three years.<ref>[http://www.wddty.com/swine-flu-alert-clears-old-stock-of-tamiflu.html Swine flu alert clears old stock of Tamiflu] (subscription req'd to see full article), 30 April 2009, WDDTY website, accessed 15 July 2009</ref>
 ==Notes==

← Older revision		Revision as of 13:18, 15 July 2009
Line 46:		Line 46:

	Patient feedback on the Askapatient.com database gives positive and negative experiences of the drug, including some reports of serious autoimmune and neurological side-effects. The overall patient satisfaction rating as at 15 July 2009 was 2.4, between "2-Not Satisfied: this medicine did not work to my satisfaction" and "3-Somewhat Satisfied: this medicine helped somewhat" (best rating would be 5, worst 1).<ref>[http://www.askapatient.com/viewrating.asp?drug=21087&name=TAMIFLU Tamiflu], Askapatient.com, accessed 14 July 2009</ref>		Patient feedback on the Askapatient.com database gives positive and negative experiences of the drug, including some reports of serious autoimmune and neurological side-effects. The overall patient satisfaction rating as at 15 July 2009 was 2.4, between "2-Not Satisfied: this medicine did not work to my satisfaction" and "3-Somewhat Satisfied: this medicine helped somewhat" (best rating would be 5, worst 1).<ref>[http://www.askapatient.com/viewrating.asp?drug=21087&name=TAMIFLU Tamiflu], Askapatient.com, accessed 14 July 2009</ref>
		+
		+	=="Swine flu clears old stock of Tamiflu" allegation==
		+
		+	The website What Doctors Don't Tell You (WDDTY) reports that swine flu has arrived at a convenient time to enable governments to clear old stockpiles of Tamiflu left over from the avian flu epidemic:
		+	"It is almost three years since we faced the hysteria of an avian flu epidemic, when governments bought billions of dollars of Tamiflu – the same anti-viral now being promoted to combat a supposed swine flu pandemic. The shelf life of Tamiflu also happens to be three years. The World Health Organization has, at the time of writing, increased its threat level to five, which means governments can activate their pandemic plans – and start handing out Tamiflu drugs. This is extremely convenient for governments that would have very soon have to dispose of billions of dollars of Tamiflu stock, which they bought to counter avian flu, or H5N1. The US government ordered 20 million doses, costing $2bn, in October, 2005, and around that time the UK government ordered 14.6 million doses. Tamiflu’s manufacturer, Roche, has confirmed that the shelf life of its anti-viral is three years.<ref>[http://www.wddty.com/swine-flu-alert-clears-old-stock-of-tamiflu.html Swine flu alert clears old stock of Tamiflu] (subscription req'd to see full article), 30 April 2009, WDDTY website, accessed 15 July 2009</ref>

	==Notes==		==Notes==

@@ Line 27: / Line 27: @@
 The [[European Medicines Agency]] ([[EMEA]]) lists similar drug side effects and adds: ‘The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations – such as a pandemic situation - seasonal prevention could be considered in individuals one year of age or older.’<ref>EMEA.[http://www.emea.europa.eu/pdfs/human/pandemicinfluenza/59210207en.pdf Updated review of of influenza antiviral medicinal products for the potential use during pandemic during the CHMP of the EMEA], 13 December 2007, Accessed on 10 May 2009.</ref>
-==Extended Clinical Trials and Developments==
+==Extended clinical trials and developments==
 *In July 2009, [[Roche]] announced it was to start clinical trials to see if Tamiflu was more effective when taken in higher doses over a longer period of time - up to twice the length of the recommended five day period. <ref>Jack, A. [http://www.ft.com/cms/s/0/3dca6dc2-6f0a-11de-9109-00144feabdc0.html?ftcamp=rss&nclick_check=1 Roche looks at extensions to Tamiflu.] Accessed on 12 July 2009.</ref>

@@ Line 1: / Line 1: @@
 {{Template:Pharma_Portal_badge}}
-[[Tamiflu]] (generic name: Oseltamivir or oseltamivir phosphate) is a drug designed to block the influenza virus from spreading between cells in the body. It is an antiviral which is used in the treatment and prevention of influenza A and influenza B viruses and should be taken within 48 hours of experiencing flu-like symptoms to be effective.<ref> Tamiflu. [http://www.tamiflu.com/treat.aspx Tamiflu for flu treatment] Accessed 15 July 2009.</ref>
+[[Tamiflu]] (generic name: [[Oseltamivir]] or [[Oseltamivir Phosphate]]) is a drug designed to block the influenza virus from spreading between cells in the body. It is an antiviral which is used in the treatment and prevention of influenza A and influenza B viruses and should be taken within 48 hours of experiencing flu-like symptoms to be effective.<ref> Tamiflu. [http://www.tamiflu.com/treat.aspx Tamiflu for flu treatment] Accessed 15 July 2009.</ref>
 The drug was invented by [[Gilead Sciences]] and licensed to [[Roche]] in 1996. The two companies ended an ongoing dispute over the Development and License Agreement for Tamiflu in 2005 due to the 'threat of an influenza pandemic in particular related to the growing incidence of avian influenza' and the need 'to address public health needs'. <ref>Gilead Sciences. [http://www.gilead.com/pr_783456 Gilead and Roche End Tamiflu® Dispute; Expanded Collaboration Includes Gilead Role in Oversight of Manufacturing and Commercialization] Accessed on 14 July 2009.</ref>

@@ Line 45: / Line 45: @@
 Also mentioned among the severe side-effects is "Abnormal behavior and delirium leading to injury, with fatal outcomes in some cases".<ref>[http://www.drugs.com/sfx/tamiflu-side-effects.html#system_15363 Side Effects of Tamiflu - for the consumer], Drugs.com, accessed 14 July 2009</ref>
-Patient feedback on the Askapatient gives positive and negative experiences of the drug, including some reports of serious autoimmune and neurological side-effects. The overall patient satisfaction rating as at 15 July 2009 was 2.4, between "2-Not Satisfied: this medicine did not work to my satisfaction" and "3-Somewhat Satisfied: this medicine helped somewhat" (best rating would be 5, worst 1).<ref>[http://www.askapatient.com/viewrating.asp?drug=21087&name=TAMIFLU Tamiflu], Askapatient.com, accessed 14 July 2009</ref>
+Patient feedback on the Askapatient.com database gives positive and negative experiences of the drug, including some reports of serious autoimmune and neurological side-effects. The overall patient satisfaction rating as at 15 July 2009 was 2.4, between "2-Not Satisfied: this medicine did not work to my satisfaction" and "3-Somewhat Satisfied: this medicine helped somewhat" (best rating would be 5, worst 1).<ref>[http://www.askapatient.com/viewrating.asp?drug=21087&name=TAMIFLU Tamiflu], Askapatient.com, accessed 14 July 2009</ref>
 ==Notes==

@@ Line 35: / Line 35: @@
 *[[Roche]] halved the price of Tamiflu for the world's developing countries following the swine flu pandemic. <ref>Jack, A. [http://www.ft.com/cms/s/0/898c707e-66a0-11de-a034-00144feabdc0.html Tamiflu price cut for poorest countries.] Accessed on 12 July 2009.</ref>
 ==Notes==
 <references/>
 [[Category: Big Pharma]]
 [[Category: Pharma]]